Safety Net
Posted on June 17, 2013 by A&U in LifeGuide, Treatment Horizons
Treatment Horizons by Chael Needle A nonprofit creates a new support system for the uninsured Joining Merck and ViiV Healthcare, Gilead Sciences is now supporting and participating in a new patient assistance program (PAP) that provides individuals living with HIV/AIDS and in treatment with a singular portal to free medications. Launched in the summer of [...]
Man to Man
Posted on May 29, 2013 by A&U in Hep Talk, LifeGuide
Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the hepatitis C virus (HCV). This time it’s a study, presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in March in Atlanta, that showed adding telaprevir [...]
Cuts to Healthcare
Posted on May 28, 2013 by A&U in LifeGuide, Treatment Horizons
Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes increases in funding for ADAP and the various components of Ryan White and sustained or increased funding for CDC prevention services, HOPWA, and NIH and the Veterans Administration. [...]
Invisible Disease
Posted on May 6, 2013 by A&U in Hep Talk, LifeGuide
Hep Talk by Larry Buhl Organizations shine a light on HCV in jails and prisons The percentage of people chronically infected with hepatitis C (HCV) in jails, prisons, and other correctional facilities is between fifteen and thirty percent, according to latest estimates—now more than ten years old—by the CDC. Why the wide window? Because testing [...]
HIV Latency & HDACs
Posted on April 18, 2013 by A&U in LifeGuide, Treatment Horizons
Hide and Seek Led by Dr. Daria Hazuda, researchers tackle HIV latency with HDAC inhibitors by Chael Needle With all the talk around viral suppression, it may seem odd at first to hear that researchers are looking for agents that reactivate HIV in the body, but not once you remember that HIV has the ability [...]
The Silent C
Posted on April 8, 2013 by A&U in Hep Talk, LifeGuide
A new recommendation report provides a global look at hepatitis C Hep Talk by Larry Buhl There’s good news and bad news about the hepatitis C epidemic, according to a new report titled, “The Silent Pandemic: Tackling Hepatitis C with Policy Innovation.” The good news: There are many new, effective drugs available and in the [...]
Skin Cancers Revisited
Posted on April 3, 2013 by A&U in LifeGuide, Treatment Horizons
Sun Blocked A new study examines non-melanoma skin cancers & HIV by Chael Needle In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated a particular set of urgent health concerns. Now that treatment often affords longer life for HIV-positive individuals, HIV disease is increasingly intersecting with health concerns related to lifestyle [...]
Bathroom Reading
Posted on March 1, 2013 by A&U in LifeGuide, Treatment Horizons
A newly approved anti-diarrheal agent seeks to counter side effects of HAART by Chael Needle Recently, the FDA approved Fulyzaq (crofelemer) 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients living with HIV/AIDS who are also on antiretroviral therapy. Available in early 2013 from Salix Pharmaceuticals, which develops and markets [...]
Year in Review
Posted on February 25, 2013 by A&U in Hep Talk, LifeGuide
What were the top five HCV-related stories of 2012? by Larry Buhl There were many important news stories about hepatitis in 2012. In this column we review the biggest Hep Talk stories of the past year and cover a few that slipped through the cracks. The developments with the biggest possible impacts were the Centers [...]
Flipping the Script
Posted on January 22, 2013 by A&U in LifeGuide, Wellness Watch
Walgreens dispenses vital support through HIV-specialized pharmacies Wellness Watch by Chael Needle Individuals living with HIV/AIDS and in treatment may not know that one pharmacy may be different from the next when it comes to addressing their needs. Walgreens, a national pharmacy chain, wants them to know that HIV-sensitive support exists in a safe environment—free-of-charge, [...]
